BS
NTLA icon

Banco Santander’s Intellia Therapeutics NTLA Stock Holding History

Banco Santander’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Hold
13,029
– – ﹤0.01% 485
2026
Q1 		$167K Hold
13,029
– – ﹤0.01% 462
2025
Q4 		$117K Buy
+13,029
New +$179K ﹤0.01% 450
2022
Q2 		– Sell
-180,000
Closed -$13.1M – 423
2022
Q1 		$13.1M Hold
180,000
– – 0.14% 94
2021
Q4 		$21.3M Hold
180,000
– – 0.11% 56
2021
Q3 		$24.1M Buy
+180,000
New +$27.3M 0.13% 55

Other funds holding NTLA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Banco Santander's NTLA Position: Q2 2026 in Review

Banco Santander held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 13,029 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Banco Santander first reported a position in NTLA in Q3 2021 and has held it in 6 quarters since. The position peaked at $24.1M in Q3 2021. 130 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Banco Santander held 13,029 shares of Intellia Therapeutics worth $220K as of Q2 2026.
  • Banco Santander left its Intellia Therapeutics share count unchanged in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Banco Santander's portfolio in Q2 2026, its #485 holding.
  • Banco Santander first reported a position in Intellia Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • Banco Santander's Intellia Therapeutics position peaked at $24.1M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.